Publicaciones en las que colabora con Rafael Cantón Moreno (8)

2024

  1. In vitro activity of cefiderocol and other newly approved antimicrobials against multi-drug resistant Gram-negative pathogens recovered in intensive care units in Spain and Portugal

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 37, Núm. 1, pp. 69-77

2018

  1. Susceptibility testing and detection of β-lactam resistance mechanisms in Enterobacteriaceae: a multicentre national proficiency study

    International Journal of Antimicrobial Agents, Vol. 51, Núm. 4, pp. 612-619

2017

  1. Etestw versus broth microdilution for ceftaroline MIC determination with Staphylococcus aureus: Results from PREMIUM, a European multicentre study

    Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 2, pp. 431-436

2016

  1. Estudios de coste-efectividad con MALDI-TOF e impacto clínico

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 34, pp. 47-52

2014

  1. Detection of resistance to beta-lactamase inhibitors in strains with CTX-M beta-lactamases: A multicenter external proficiency study using a well-defined collection of escherichia coli strains

    Journal of Clinical Microbiology, Vol. 52, Núm. 1, pp. 122-129

2013

  1. Activity of oritavancin against methicillin-resistant staphylococci, vancomycin-resistant enterococci and β-haemolytic streptococci collected from western European countries in 2011

    Journal of Antimicrobial Chemotherapy, Vol. 68, Núm. 1, pp. 164-167

2010

  1. Actividad comparativa de doripenem, meropenem e imipenem en aislados recientes obtenidos durante el estudio de vigilancia epidemiológica COMPACT-España

    Revista Espanola de Quimioterapia, Vol. 23, Núm. 3, pp. 144-152

1995

  1. Multicentre comparative study on the antibacterial activity of FK-037, a new parenteral cephalosporin

    European Journal of Clinical Microbiology & Infectious Diseases, Vol. 14, Núm. 3, pp. 244-252